In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the updates for ...frail and high-risk patients presented at ASH 2022.[+] Show More
active
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the updates for ...frail and high-risk patients presented at ASH 2022.[+] Show More
active
In this video, Dr Sonja Zweegman, Amsterdam University Medical ...
In this video, Dr Sonja Zweegman, Amsterdam University Medical Centers, Cancer Centers Amsterdam, the Netherlands, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the myeloma updates ...and the data she and her team presented at ASH 2022.[+] Show More
active
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains if CAR T-cell ...therapy is being explored for the treatment of AL amyloidosis.[+] Show More
active
Professor Efstathios Kastritis, Associate Professor at the National ...
Professor Efstathios Kastritis, Associate Professor at the National and Kapodistrian University of Athens, Athens, Greece, explains the main AL amyloidosis highlights presented at ASH 2022.
active
In this video, Dr Charlotte Pawlyn, Haematology Consultant, Royal ...
In this video, Dr Charlotte Pawlyn, Haematology Consultant, Royal Marsden Hospital, London, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the latest bispecific antibodies updates presented ...at ASH 2022.[+] Show More
active
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, ...
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, University Hospital Ostrava, Czech Republic, explains in this video the key highlights presented at the American Society of Hematology annual ...meeting 2022.[+] Show More
active
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, ...
Dr Roman Hajek, Head of the Department of Clinical Hematooncology, University Hospital Ostrava, Czech Republic, explains the main Minimal Residual Disease (MRD) updates presented at the American Society of Hematology ...annual meeting 2022.[+] Show More
active
Dr Charlotte Pawlyn, Haematology Consultant, Royal Marsden Hospital, ...
Dr Charlotte Pawlyn, Haematology Consultant, Royal Marsden Hospital, London, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee, explains the latest CAR-T therapy updates presented at ASH 2022.
active
Dr Meletios Dimopoulos, Chairman of the Department of Clinical ...
Dr Meletios Dimopoulos, Chairman of the Department of Clinical Therapeutics at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece, explains in this video the key highlights ...presented at ASH 2022 and the abstracts he and his team presented at the meeting. You can watch the interview here.[+] Show More
active
COVID-19, and how it affects to myeloma and AL amyloidosis patients, ...
COVID-19, and how it affects to myeloma and AL amyloidosis patients, was discussed during ASH 2022. Dr Meletios Dimopoulos, Chairman of the Department of Clinical Therapeutics at the National and ...Kapodistrian University of Athens School of Medicine, Athens, Greece, explains in this video the latest updates on COVID-19 presented.[+] Show More
active
Lenalidomide maintenance after autologous stem cell transplant (ASCT) ...
Lenalidomide maintenance after autologous stem cell transplant (ASCT) is standard of care for myeloma patients. Defining the optimal duration of this maintenance treatment is an important question explored in the ...Myeloma XI clinical trial. Dr Charlotte Pawlyn, Haematology Consultant, Royal Marsden Hospital, London, and member of the Myeloma Patients Europe (MPE) Medical Advisory Committee explains the findings from research presented at ASH 2022.[+] Show More
active
This is a recording of Prof. Dr. Karanfilski giving a summary of the ...
English
Armenian
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hungarian
Icelandic
Italian
Latvian
Lithuanian
Macedonian
Norwegian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Turkish
